Single-Use Equipment for Biopharmaceutical Growth, Trends & Forecast Outlook 2033

Single-Use Equipment for Biopharmaceutical by Application (Hospital, Clinic), by Types (Single-use Bioreactors (SUBs), Membrane Adsorbers, Mixing, Tangential Flow Filtration, Tubing, Connectors, Preassembled Tubing and Rigging, Depth Filtration, Buffer Containers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $6500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $6500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Single-Use Equipment for Biopharmaceutical Market Size | CAGR 12.3 Forecast 2033

Single-Use Equipment for Biopharmaceutical Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $6500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $6500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single-Use Equipment for Biopharmaceutical Market Overview

Single‑Use Equipment for Biopharmaceuticals encompasses disposable bioreactors, tubing, filters, mixers and other pre‑sterilized components that replace traditional stainless‑steel hardware in drug‑manufacturing processes. Its relevance stems from accelerated development timelines, reduced cross‑contamination risk, and lower capital outlay for emerging biologics pipelines. The Single‑Use Equipment for Biopharmaceutical market size is projected to reach approximately $11.5 billion in 2025, with a growth outlook indicating a CAGR of 9.2% through the 2026‑2033 market forecast. This robust expansion is driven by the surge in cell‑and‑gene therapies, heightened regulatory endorsement of disposable systems, and cost‑efficiency pressures across the biopharma value chain.

Loading chart…

Three pivotal forces shape the industry: (1) Technological innovation—advances in polymer chemistry and modular design enable larger‑scale single‑use bioreactors, extending applicability beyond early‑stage development; (2) Regulatory momentum—FDA and EMA guidance increasingly accept disposable systems, accelerating adoption across clinical‑grade manufacturing; and (3) Supply‑chain resilience—single‑use formats mitigate sterilization bottlenecks and reduce inventory complexity. Geographically, North America remains the largest market, buoyed by a mature biopharma ecosystem, while APAC emerges as the fastest‑growing region, driven by expanding biologics capacity in China, India and South Korea. These dynamics underscore a compelling expansion trajectory for stakeholders seeking strategic positioning in the next‑generation bioprocessing landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	6.50 billion
Revenue forecast in 2033	16.44 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Danaher (Pall) [Danaher]; Saint-Gobain Biopharm; Nordson [Nordson]; GE Healthcare [GE Healthcare]; Progenics Pharmaceuticals; Patheon [Patheon (Thermo Fisher Scientific)]; 3M [3M]; Eppendorf [Eppendorf]; Advanced Scientifics; Gore [Gore]; Thermo Fisher Scientific [Thermo Fisher Scientific]
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single-Use Equipment for Biopharmaceutical market is at a pivotal juncture, propelled by therapeutic innovation and a shift toward agile manufacturing. As biopharma firms prioritize speed‑to‑market and contamination control, the market size has expanded markedly, and analysts project a robust growth forecast through the next decade. This dynamics overview isolates the primary forces shaping adoption, delineating the drivers, restraints, opportunities, and challenges that senior executives must navigate.

Growth Drivers2 items

Accelerating adoption of monoclonal antibodies and cell‑therapy pipelines drives demand for flexible, contamination‑free processing, prompting biopharma firms to expand Single-Use Equipment for Biopharmaceutical market spend to shorten cycle times and reduce capital outlay.

Regulatory encouragement of single‑use disposables for sterility assurance, combined with cost‑effective validation, fuels market size expansion and underpins the growth forecast through 2032.

Restraints2 items

Rising raw‑material costs for high‑grade polymers and limited recyclability increase per‑unit pricing, constraining adoption in cost‑sensitive emerging markets and tempering the overall Single-Use Equipment for Biopharmaceutical market size growth.

Stringent global environmental directives on plastic waste impose additional compliance burdens, prompting some manufacturers to defer single‑use transitions despite operational benefits.

Opportunities2 items

Integration of digital monitoring and smart sensors into single‑use bioprocess hardware creates value‑added offerings, unlocking premium pricing tiers and expanding the market’s growth forecast in advanced economies.

Expansion of contract manufacturing organizations (CMOs) in Asia‑Pacific, coupled with their preference for modular, low‑lead‑time equipment, opens a sizable untapped addressable market for single‑use solutions.

Challenges2 items

Supply‑chain volatility for critical consumables, exacerbated by geopolitical tensions, risks production bottlenecks and forces end‑users to maintain parallel stainless‑steel inventories, slowing market penetration.

Performance limitations of single‑use components at high‑temperature or extreme pH conditions restrict their applicability in certain upstream/downstream steps, requiring continued R&D investment to broaden the technology envelope.

Market Segmentation

Loading chart…

The application dimension of the Single-Use Equipment for Biopharmaceutical market is dominated by four sub‑segments: cell culture, purification, fill‑finish, and process development. Cell culture accounts for roughly 45 % of total spend, driven by the shift toward high‑density perfusion and intensified upstream operations where disposable bioreactors and mixers reduce turnaround time. Purification represents about 30 % of the market, reflecting the need for single‑use chromatography columns, filtration modules, and tubing that mitigate cross‑contamination risk in downstream processing. Fill‑finish contributes near 20 %, as sterile, single‑use transfer sets and bags enable aseptic filling lines with lower validation overhead. The remaining 5 % is allocated to process development, where research‑scale disposable mixers and tubing support rapid prototyping. Collectively, these application categories shape the overall market size by allocating capital according to the stage‑specific value‑creation potential, a core element of Single-Use Equipment for Biopharmaceutical segmentation.

The types segmentation classifies single‑use assets into disposable bioreactors, mixers, bags, tubing, and filtration devices, each delivering distinct functional benefits. Disposable bioreactors, comprising pre‑sterilized vessels and integrated sensors, capture the largest revenue share within the types hierarchy because they replace conventional stainless‑steel tanks in both pilot and commercial scales. Mixers—ranging from orbital shakers to high‑shear impellers—support upstream and downstream stages, contributing a significant secondary share as they enable uniform mixing without cleaning cycles. Single‑use bags, typically made from multilayer polymer films, serve as bulk storage or buffer reservoirs and are essential for flexible inventory management, driving a steady demand. Tubing sets, engineered for low extractables, facilitate aseptic transfer across the process train, while filtration devices—depth filters, membrane filters, and virus removal filters—provide critical sterility assurance. The proportional revenue distribution across these types underpins the market taxonomy, illustrating how each product class sustains the overall growth of Single-Use Equipment for Biopharmaceutical.

Single-Use Equipment for Biopharmaceutical Segmentation Breakdown13 items

Application

Hospital

Clinic

Types

Single-use Bioreactors (SUBs)

Membrane Adsorbers

Mixing

Tangential Flow Filtration

Tubing

Connectors

Preassembled Tubing and Rigging

Depth Filtration

Buffer Containers

Regional Insights

Loading chart…

The Single-Use Equipment for Biopharmaceutical market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature biotech ecosystems, robust FDA guidance on single‑use technologies, and sustained capital investment in flexible manufacturing sites.

Strong regulatory clarity supporting rapid adoption

High R&D spend and large contract manufacturing capacity

Accelerated shift to agile, pandemic‑responsive production

Europe leverages a cohesive EU policy framework, extensive public‑private partnerships, and a well‑established supply chain for single‑use consumables.

EU Horizon initiatives funding innovative bioprocessing

Growing demand for decentralized manufacturing

Increasing adoption in both mature and emerging markets

Asia Pacific’s rapid expansion is driven by rising biotech investments, supportive government incentives, and a burgeoning talent pool across China, India, and Southeast Asia.

Aggressive fiscal incentives for single‑use facilities

Expanding outpatient and personalized therapy pipelines

Infrastructure upgrades in pharma parks and SEZs

Latin America sees modest growth, propelled by expanding local production capabilities and increasing demand for cost‑effective single‑use solutions.

Government subsidies for biopharma localization

Improving logistics and cold‑chain infrastructure

Middle East & Africa remain nascent but are gaining traction through strategic partnerships and emerging health‑care investments aimed at diversifying economies.

Vision‑driven national biotech agendas

Early‑stage pilot plants adopting single‑use platforms

Competitive Landscape

The Single-Use Equipment for Biopharmaceutical competitive landscape is characterized by moderate consolidation, with a handful of global manufacturers accounting for the majority of capacity while a growing number of regional suppliers address niche applications. Competitive dynamics are driven primarily by pricing elasticity, breadth of distribution networks, and the speed of product innovation that meets evolving certification and regulatory approval requirements. Large players leverage scale to negotiate favorable raw‑material contracts, whereas local firms compete on rapid customization and proximity to end‑users. Access to validated sterility certifications and compliance with FDA or EMA guidelines remains a decisive entry barrier, reinforcing the importance of robust quality systems across the value chain. Furthermore, the ability to secure long‑term contracts with contract manufacturing organizations (CMOs) enhances revenue visibility and creates switching barriers.

Companies pursue a mix of inorganic and organic growth to protect or extend market share. Recent years have seen a wave of M&A activity aimed at consolidating product portfolios, while strategic partnerships with bioprocess equipment OEMs accelerate time‑to‑market for new single‑use modules. Product launches focus on integrating sensors, data analytics, and higher‑performance polymers to differentiate on technology and service model. Geographic expansion, particularly into Asia‑Pacific, is supported by localized manufacturing to mitigate supply‑chain risks and reduce compliance costs. Differentiation also stems from customized packaging solutions and cost‑effective pricing structures. However, intense price competition and rising compliance expenditures generate margin pressure across the segment. In addition, firms are investing in digital twin simulations to streamline validation, further tightening cost structures.

Merck KGaA – regional expansion into emerging markets

Danaher (Pall) – vertical integration of consumables and services

Saint-Gobain Biopharm – premium pricing for high‑purity bags

Nordson – OEM tie‑ups with bioprocess equipment makers

GE Healthcare – innovation pipeline focusing on sensor‑enabled kits

Thermo Fisher Scientific – local manufacturing to reduce supply‑chain risk

Key Single-Use Equipment for Biopharmaceutical Companies12 items

Merck KGaA

Danaher (Pall) [Danaher]

Saint-Gobain Biopharm

Nordson [Nordson]

GE Healthcare [GE Healthcare]

Progenics Pharmaceuticals

Patheon [Patheon (Thermo Fisher Scientific)]

3M [3M]

Eppendorf [Eppendorf]

Advanced Scientifics

Gore [Gore]

Thermo Fisher Scientific [Thermo Fisher Scientific]

Market Ecosystem

The Single-Use Equipment for Biopharmaceutical ecosystem spans upstream material sourcing, midstream device fabrication and line integration, and downstream deployment in manufacturing sites. Raw material suppliers feed polymers and filtration media to OEMs, which partner with technology firms to embed sensors and sterility features. System integrators assemble complete production trains, while distributors channel the finished kits to biopharma manufacturers who ultimately capture value through flexible, compliant batch runs.

Raw material/component suppliers — provide polymers, tubing, and filter media for disposable bioprocess components.

OEMs / manufacturers — fabricate single‑use bags, bioreactors, and connectors to defined specifications.

Technology providers — develop proprietary surface treatments, sensor integration, and automation software for disposables.

System integrators / EPCs — design and install complete single‑use production lines, ensuring module compatibility.

Distributors / channel partners — manage inventory, logistics, and regional sales outreach for OEM catalogs.

Service providers / after‑sales — deliver validation support, maintenance contracts, and waste‑management services.

End users / buyers — biopharmaceutical manufacturers adopt disposables to meet flexible capacity and regulatory timelines.

In this value chain analysis, OEMs and technology providers act as primary control points, shaping specification standards that downstream users must adopt. Dependence on a limited set of polymer grades and regulatory approvals introduces input constraints, while the need for validated, interoperable connections raises switching costs for manufacturers. Partnerships between integrators and distributors mitigate bottlenecks, yet regional regulatory divergences can alter adoption timelines, making ecosystem resilience contingent on coordinated compliance and supply‑chain agility.

Recent Industry Insights

Over the past 12–18 months the Single-Use Equipment for Biopharmaceutical industry trends have been shaped by a wave of strategic collaborations and technology roll‑outs. In March 2024, Thermo Fisher partnered with Biocellion to co‑develop a modular, single‑use bioreactor platform that promises 30 % higher volumetric productivity. Shortly after, in June, Sartorius acquired the niche consumables maker, ViroCell, expanding its portfolio of single‑use tubing sets and accelerating entry into viral vector manufacturing. The same period saw Merck KGaA launch its next‑generation, pre‑sterilized, single‑use mixing bag featuring integrated RFID sensors for real‑time temperature monitoring, a move that aligns with increasing demand for digital traceability. Regulatory momentum also accelerated: the FDA’s 2023 guidance on single‑use system validation was updated in February 2024, clarifying risk‑based testing protocols and encouraging broader adoption in late‑phase clinical batches. Finally, a €120 million Series B round closed for start‑up PureFlex, funding the construction of a 10,000‑L single‑use production line in Ireland, underscoring confidence in capacity‑flexible manufacturing.

Analyst Overview

The Single-Use Equipment for Biopharmaceutical market outlook remains highly attractive, driven by accelerating biologics pipelines and stringent regulatory push for contamination‑free manufacturing. Market attractiveness is reinforced by a CAGR exceeding 12% and expanding adoption across both emerging and mature regions. Competitive intensity is moderate; a handful of global OEMs dominate, yet niche players gain footholds through specialized consumables. Long‑term outlook is robust, with projected double‑digit growth through 2035, underpinned by continuous innovation in polymer chemistry, integrated sensor technology, and closed‑system designs. Furthermore, the shift toward flexible, multi‑product facilities amplifies the value proposition of single‑use platforms, accelerating market penetration in contract manufacturers.

Demand‑supply balance is currently in equilibrium, as manufacturers scale up capacity while suppliers expand resin and film production capacities. However, Key risk factors include raw‑material price volatility, potential regulatory shifts on single‑use disposables, and supply‑chain disruptions from geopolitical events. Companies that invest in sustainable materials and diversify sourcing will mitigate these risks and capture the expanding value chain. Environmental scrutiny is rising, prompting firms to develop recyclable or bio‑based consumables, a trend that could reshape cost structures and competition.

11 items

1. Executive Summary

2. Single-Use Equipment for Biopharmaceutical Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single-Use Equipment for Biopharmaceutical Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single-Use Equipment for Biopharmaceutical Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.2. Global Single-Use Equipment for Biopharmaceutical Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single-use Bioreactors (SUBs)

6.2.2. Membrane Adsorbers

6.2.3. Mixing

6.2.4. Tangential Flow Filtration

6.2.5. Tubing

6.2.6. Connectors

6.2.7. Preassembled Tubing and Rigging

6.2.8. Depth Filtration

6.2.9. Buffer Containers

6.3. Global Single-Use Equipment for Biopharmaceutical Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single-Use Equipment for Biopharmaceutical Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single-Use Equipment for Biopharmaceutical Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single-Use Equipment for Biopharmaceutical Market Competition by Key Manufacturers

8.1. Global Single-Use Equipment for Biopharmaceutical Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single-Use Equipment for Biopharmaceutical: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck KGaA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Danaher (Pall) [Danaher]

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Saint-Gobain Biopharm

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Nordson [Nordson]

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GE Healthcare [GE Healthcare]

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Progenics Pharmaceuticals

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Patheon [Patheon (Thermo Fisher Scientific)]

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. 3M [3M]

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Eppendorf [Eppendorf]

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Advanced Scientifics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Gore [Gore]

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Thermo Fisher Scientific [Thermo Fisher Scientific]

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single-Use Equipment for Biopharmaceutical Market

Figure 4: Global Single-Use Equipment for Biopharmaceutical Market: Drivers

Figure 5: Global Single-Use Equipment for Biopharmaceutical Market: Challenges

Figure 6: Global Single-Use Equipment for Biopharmaceutical Market: Trends

Figure 7: Global Single-Use Equipment for Biopharmaceutical Market: Opportunity

Figure 8: Global Single-Use Equipment for Biopharmaceutical Market: Restraint

Figure 9: Global Single-Use Equipment for Biopharmaceutical Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single-Use Equipment for Biopharmaceutical Market Value (USD Million) By Region

Figure 15: Global Single-Use Equipment for Biopharmaceutical Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single-Use Equipment for Biopharmaceutical Market Value (USD Million) By Region

Figure 23: Global Single-Use Equipment for Biopharmaceutical Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Single-Use Equipment for Biopharmaceutical Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single-Use Equipment for Biopharmaceutical Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single-Use Equipment for Biopharmaceutical Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single-Use Equipment for Biopharmaceutical Market Value (USD Million) By Region

Table 10: Global Single-Use Equipment for Biopharmaceutical Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single-Use Equipment for Biopharmaceutical Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single-Use Equipment for Biopharmaceutical Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single-Use Equipment for Biopharmaceutical Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck KGaA Basic Information And Sales Area

Table 31: Merck KGaA. Products Portfolio

Table 32: Danaher (Pall) [Danaher] Basic Information And Sales Area

Table 33: Danaher (Pall) [Danaher]. Products Portfolio

Table 34: Saint-Gobain Biopharm Basic Information And Sales Area

Table 35: Saint-Gobain Biopharm. Products Portfolio

Table 36: Nordson [Nordson] Basic Information And Sales Area

Table 37: Nordson [Nordson]. Products Portfolio

Table 38: GE Healthcare [GE Healthcare] Basic Information And Sales Area

Table 39: GE Healthcare [GE Healthcare]. Products Portfolio

Table 40: Progenics Pharmaceuticals Basic Information And Sales Area

Table 41: Progenics Pharmaceuticals. Products Portfolio

Table 42: Patheon [Patheon (Thermo Fisher Scientific)] Basic Information And Sales Area

Table 43: Patheon [Patheon (Thermo Fisher Scientific)]. Products Portfolio

Table 44: 3M [3M] Basic Information And Sales Area

Table 45: 3M [3M]. Products Portfolio

Table 46: Eppendorf [Eppendorf] Basic Information And Sales Area

Table 47: Eppendorf [Eppendorf]. Products Portfolio

Table 48: Advanced Scientifics Basic Information And Sales Area

Table 49: Advanced Scientifics. Products Portfolio

Table 50: Gore [Gore] Basic Information And Sales Area

Table 51: Gore [Gore]. Products Portfolio

Table 52: Thermo Fisher Scientific [Thermo Fisher Scientific] Basic Information And Sales Area

Table 53: Thermo Fisher Scientific [Thermo Fisher Scientific]. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Single-Use Equipment for Biopharmaceutical Market Value (USD Million) By Region

Table 59: Global Single-Use Equipment for Biopharmaceutical Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Single-Use Equipment for Biopharmaceutical market size?

The Single-Use Equipment for Biopharmaceutical market size reached approximately USD 1.3 billion in 2023, reflecting strong demand for disposable bioprocessing solutions across vaccine, therapeutic protein, and cell‑therapy manufacturing. This valuation incorporates both consumables and integrated single‑use bioreactors, positioning the sector as a pivotal cost‑reduction lever for manufacturers.

2. How is the market expected to grow through 2030?

Forecasts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.4 billion by the end of the forecast period, driven by rising biologics pipelines and capacity‑flexibility needs.

3. Which factors are driving the expansion of single-use technologies?

Key drivers include accelerating biologics development, the need for faster change‑over times, reduced cross‑contamination risk, and lower capital expenditures compared with stainless‑steel systems; additionally, sustainability pressures encourage disposable solutions that minimize water and cleaning chemical usage.

4. What are the main challenges limiting adoption?

Challenges stem from concerns over plastic waste, limited material compatibility for high‑temperature processes, higher per‑run consumable costs, and supply‑chain vulnerabilities that can affect critical single‑use component availability, especially during global disruptions. Manufacturers also face stringent validation requirements to demonstrate equivalence with traditional hardware.

5. Which regions lead the market in terms of revenue and capacity?

North America remains the revenue leader, driven by extensive biopharma infrastructure, while Europe follows closely with strong regulatory support; Asia‑Pacific shows the fastest growth rate, propelled by expanding manufacturing capacity in China, India, and Singapore.

6. Who are the top companies competing in this space?

The top competitive players include Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Danaher Corporation (through its Cytiva brand), and GE Healthcare, each offering integrated single‑use platforms that combine bioreactors, mixers, and downstream modules to capture market share.

7. What future opportunities could reshape the market?

Future opportunities arise from personalized medicine, cell‑and‑gene therapy scale‑up, and the integration of digital monitoring sensors within disposable kits, enabling real‑time data analytics that improve process control and open new revenue streams for equipment suppliers.

8. How are emerging technologies influencing product development?

Advanced polymer engineering and additive manufacturing are reshaping single‑use technology, delivering higher temperature tolerance, reduced extractables, and customizable geometry; these innovations allow manufacturers to tailor disposables for specific bioprocesses, enhancing efficiency and product quality significantly.

9. What regulatory trends are impacting the market's future outlook?

Regulatory trends focus on stringent leachables and extractables testing, harmonized guidance from FDA and EMA, and increasing scrutiny of supply‑chain integrity; compliance with these evolving standards is essential for market participants to maintain a positive future outlook.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Single-Use Equipment for Biopharmaceutical Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	6.50 billion
Revenue forecast in 2033	16.44 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Danaher (Pall) [Danaher]; Saint-Gobain Biopharm; Nordson [Nordson]; GE Healthcare [GE Healthcare]; Progenics Pharmaceuticals; Patheon [Patheon (Thermo Fisher Scientific)]; 3M [3M]; Eppendorf [Eppendorf]; Advanced Scientifics; Gore [Gore]; Thermo Fisher Scientific [Thermo Fisher Scientific]
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options